JP2023532665A5 - - Google Patents

Info

Publication number
JP2023532665A5
JP2023532665A5 JP2022580050A JP2022580050A JP2023532665A5 JP 2023532665 A5 JP2023532665 A5 JP 2023532665A5 JP 2022580050 A JP2022580050 A JP 2022580050A JP 2022580050 A JP2022580050 A JP 2022580050A JP 2023532665 A5 JP2023532665 A5 JP 2023532665A5
Authority
JP
Japan
Prior art keywords
host cell
exogenous
soi
nucleotides
targeted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022580050A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023532665A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/038599 external-priority patent/WO2021262798A1/en
Publication of JP2023532665A publication Critical patent/JP2023532665A/ja
Publication of JP2023532665A5 publication Critical patent/JP2023532665A5/ja
Pending legal-status Critical Current

Links

JP2022580050A 2020-06-24 2021-06-23 核酸の標的化組み込み Pending JP2023532665A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063043409P 2020-06-24 2020-06-24
US63/043,409 2020-06-24
PCT/US2021/038599 WO2021262798A1 (en) 2020-06-24 2021-06-23 Targeted integration of nucleic acids

Publications (2)

Publication Number Publication Date
JP2023532665A JP2023532665A (ja) 2023-07-31
JP2023532665A5 true JP2023532665A5 (https=) 2024-07-01

Family

ID=77168386

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022580050A Pending JP2023532665A (ja) 2020-06-24 2021-06-23 核酸の標的化組み込み

Country Status (10)

Country Link
US (2) US20210403943A1 (https=)
EP (1) EP4172346A1 (https=)
JP (1) JP2023532665A (https=)
KR (1) KR20230027043A (https=)
CN (1) CN116096907A (https=)
CA (1) CA3172453A1 (https=)
IL (1) IL299120A (https=)
MX (1) MX2022015205A (https=)
TW (1) TW202216991A (https=)
WO (1) WO2021262798A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI840799B (zh) * 2022-05-02 2024-05-01 國立臺灣海洋大學 水產生物及水產品之外源性分子追溯方法及其系統
KR20250107893A (ko) * 2022-11-15 2025-07-14 제넨테크, 인크. 숙주 세포로의 트랜스포존 매개 통합 및 핵산의 표적 통합의 조합
WO2024229085A2 (en) * 2023-05-01 2024-11-07 Washington State University Mouse model with humanized telomere

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE913929A1 (en) 1990-11-13 1992-05-20 Immunex Corp Bifunctional selectable fusion genes
AU6953394A (en) 1993-05-21 1994-12-20 Targeted Genetics Corporation Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
JP2008501621A (ja) 2003-05-31 2008-01-24 マイクロメット アクツィエン ゲゼルシャフト B細胞関連疾患を処置するための二重特異性抗cd3、抗cd19抗体構築物を含む薬学的組成物
US7235641B2 (en) 2003-12-22 2007-06-26 Micromet Ag Bispecific antibodies
EP1940881B1 (en) 2005-10-11 2016-11-30 Amgen Research (Munich) GmbH Compositions comprising cross-species-specific antibodies and uses thereof
DE102007001370A1 (de) 2007-01-09 2008-07-10 Curevac Gmbh RNA-kodierte Antikörper
RS53008B2 (sr) 2007-04-03 2022-12-30 Amgen Res Munich Gmbh Interspecijski specifičan cd3-epsilon vezujući domen
NO2748201T3 (https=) 2011-08-23 2018-05-12
WO2013026839A1 (en) 2011-08-23 2013-02-28 Roche Glycart Ag Bispecific antibodies specific for t-cell activating antigens and a tumor antigen and methods of use
CN103152739A (zh) 2013-02-06 2013-06-12 北京奇虎科技有限公司 一种移动终端通话请求信息处理的方法、装置及系统
BR112015031639A2 (pt) * 2013-06-19 2019-09-03 Sigma Aldrich Co Llc integração alvo
TW201620932A (zh) 2014-03-27 2016-06-16 建南德克公司 抗-b型流感病毒血球凝集素抗體及其使用方法
EP3177643B1 (en) 2014-08-04 2019-05-08 F.Hoffmann-La Roche Ag Bispecific t cell activating antigen binding molecules
BR112017008022A2 (pt) * 2014-10-23 2018-02-20 Regeneron Pharmaceuticals, Inc. célula, polinucleotídeo, veículo, e, métodos para modificação de um genoma de células cho e para preparação de uma proteína de interesse.
US20210309988A1 (en) * 2017-02-07 2021-10-07 Sigma-Aldrich Co. Llc Stable targeted integration
IL275462B2 (en) * 2017-12-22 2026-01-01 Genentech Inc Targeted integration of nucleic acids
AU2019403279A1 (en) * 2018-12-21 2021-07-01 Genentech, Inc. Targeted integration of nucleic acids
AU2020308002A1 (en) * 2019-06-26 2022-01-20 Genentech, Inc. Randomized configuration targeted integration of nucleic acids

Similar Documents

Publication Publication Date Title
AU2020267249B2 (en) Genome editing using campylobacter jejuni crispr/cas system-derived rgen
US11555181B2 (en) Engineered cascade components and cascade complexes
KR102021585B1 (ko) 두 개의 벡터로부터 발현된 Cas9 단백질을 이용한 유전자 발현 조절 방법
JP2023516226A5 (https=)
KR102168489B1 (ko) CRISPR/Cpf1 시스템을 이용한 유전체 편집용 조성물 및 이의 용도
JP2023532665A5 (https=)
CN103343120B (zh) 一种小麦基因组定点改造方法
JP2021048882A5 (https=)
CN103382468B (zh) 一种水稻基因组定点改造方法
JP2022516130A5 (https=)
WO2023193536A1 (zh) 一种腺苷脱氨酶、碱基编辑器及应用
KR20190019931A (ko) 다중 가이드 RNAs를 이용한 면역학적 내성 파괴 방법
CA3225082A1 (en) Enzymes with ruvc domains
CN109929865B (zh) 基于gal4-uas系统的crispr辅助反式增强子激活基因表达的方法及其应用
CN110835635A (zh) 不同启动子启动多个串联sgRNA表达的质粒构建方法
US20190218533A1 (en) Genome-Scale Engineering of Cells with Single Nucleotide Precision
Hammond et al. Fluorescent and bimolecular-fluorescent protein tagging of genes at their native loci in Neurospora crassa using specialized double-joint PCR plasmids
CN110577969B (zh) CRISPR/Sa-SlugCas9基因编辑系统及其应用
CN118792281B (zh) 一种小型CRISPR-Cas系统及其应用
CA2957441C (en) Genome editing using campylobacter jejuni crispr/cas system-derived rgen
CN118979027A (zh) 一种具有提高编辑活性的先导编辑器、包含其的基因编辑系统及用途
CA2589591A1 (en) Malate synthase regulatory sequences for heterologous gene expression in pichia
CN105219777A (zh) 一种成纤维细胞特异性启动子及其应用
CN118165121A (zh) 一种包含nb237的融合蛋白、包含该融合蛋白的基因表达沉默工具及其应用
WO2025206382A1 (ja) 核酸切断酵素、核酸、ベクター、核酸改変用キット、核酸の改変方法、変異体の作製方法、遺伝子発現方法、真核細胞、ベクター又はdna断片、キット、及び遺伝子操作された真核細胞の作製方法